Show simple item record

dc.contributor.authorProsser, BE
dc.contributor.authorJohnson, S
dc.contributor.authorRoversi, P
dc.contributor.authorHerbert, AP
dc.contributor.authorBlaum, BS
dc.contributor.authorTyrrell, J
dc.contributor.authorJowitt, TA
dc.contributor.authorClark, SJ
dc.contributor.authorTarelli, E
dc.contributor.authorUhrín, D
dc.contributor.authorBarlow, PN
dc.contributor.authorSim, RB
dc.contributor.authorDay, AJ
dc.contributor.authorLea, SM
dc.date.accessioned2018-02-21T13:44:03Z
dc.date.issued2007-10-01
dc.description.abstractNearly 50 million people worldwide suffer from age-related macular degeneration (AMD), which causes severe loss of central vision. A single-nucleotide polymorphism in the gene for the complement regulator factor H (FH), which causes a Tyr-to-His substitution at position 402, is linked to approximately 50% of attributable risks for AMD. We present the crystal structure of the region of FH containing the polymorphic amino acid His402 in complex with an analogue of the glycosaminoglycans (GAGs) that localize the complement regulator on the cell surface. The structure demonstrates direct coordination of ligand by the disease-associated polymorphic residue, providing a molecular explanation of the genetic observation. This glycan-binding site occupies the center of an extended interaction groove on the regulator's surface, implying multivalent binding of sulfated GAGs. This finding is confirmed by structure-based site-directed mutagenesis, nuclear magnetic resonance-monitored binding experiments performed for both H402 and Y402 variants with this and another model GAG, and analysis of an extended GAG-FH complex.en_GB
dc.description.sponsorshipB. Prosser is funded by the Wellcome Trust Structural Biology Training Program (075415/Z/04/Z). S. Johnson and P. Roversi were funded by grants to S.M. Lea from the Medical Research Council (MRC) of the United Kingdom (grants G0400389 and G0400775). D. Uhrin and P.N. Barlow were funded by the Wellcome Trust (078780/ Z/05/Z). S.J. Clark was funded by an MRC Doctoral Training Account (G78/7925), and R.B. Sim and A.J. Day were funded by MRC core funding to the MRC Immunochemistry Unit.en_GB
dc.identifier.citationVol. 204, pp. 2277 - 2283en_GB
dc.identifier.doi10.1084/jem.20071069
dc.identifier.urihttp://hdl.handle.net/10871/31609
dc.language.isoenen_GB
dc.publisherRockefeller University Pressen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/17893204en_GB
dc.rights© The Rockefeller University Pressen_GB
dc.subjectAgingen_GB
dc.subjectBinding Sitesen_GB
dc.subjectComplement Factor Hen_GB
dc.subjectCrystallography, X-Rayen_GB
dc.subjectGene Products, gagen_GB
dc.subjectLigandsen_GB
dc.subjectModels, Molecularen_GB
dc.subjectMutationen_GB
dc.subjectPolysaccharidesen_GB
dc.subjectProtein Structure, Quaternaryen_GB
dc.subjectProtein Structure, Tertiaryen_GB
dc.subjectSucroseen_GB
dc.subjectSurface Propertiesen_GB
dc.titleStructural basis for complement factor H linked age-related macular degenerationen_GB
dc.typeArticleen_GB
dc.date.available2018-02-21T13:44:03Z
dc.identifier.issn0022-1007
exeter.place-of-publicationUnited Statesen_GB
dc.descriptionThis is the final version of the article. Available from the publisher via the DOI in this record.en_GB
dc.identifier.journalJournal of Experimental Medicineen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record